Me. Fabiani et Df. Story, EFFECTS OF CROMAKALIM, PINACIDIL AND GLIBENCLAMIDE ON CHOLINERGIC TRANSMISSION IN RAT ISOLATED ATRIA, Pharmacological research, 32(3), 1995, pp. 155-163
The effect of the potassium channel openers cromakalim and pinacidil,
and the potassium channel blocking drug glibenclamide, were investigat
ed on cholinergic transmission in rat isolated atrial preparations whi
ch had been incubated with [H-3]-choline to incorporate [H-3]acetylcho
line into the cholinergic transmitter stores. The efflux of radioactiv
ity evoked by electrical field stimulation of intrinsic parasympatheti
c nerves (pulses at 5 Hz frequency in trains of 60 s duration) was tak
en as an index of transmitter acetylcholine release. Stimulation-induc
ed (S-I) efflux of radioactivity was virtually abolished by tetrodotox
in (1 mu M) and by the removal of Ca2+ from the atrial superfusion flu
id. The muscarinic cholinoceptor antagonist atropine (0.3 mu M) and th
e alpha(2)-adrenoceptor antagonist idazoxan (0.3 mu M) each enhanced t
he S-I efflux. Cromakalim (1 and 10 mu M) produced concentration-depen
dent reductions in S-I efflux. Pinacidil (10 mu M) also reduced S-I ef
flux, The inhibition of S-I afflux produced by cromakalim (10 mu M) an
d pinacidil (10 mu M) was prevented by the ATP-sensitive potassium cha
nnel blocking drug glibenclamide (1 mu M). Moreover, glibenclamide (1
mu M) alone enhanced S-I efflux. The findings suggest that cromakalim
and pinacidil may inhibit transmitter acetylcholine release from atria
l parasympathetic nerves by activation of ATP-sensitive potassium chan
nels. In addition, the finding that glibenclamide alone enhanced S-I e
fflux in radiolabelled atrial preparations suggests that ATP-sensitive
potassium channels are activated under the experimental conditions em
ployed. Taken together, the findings indicate that, in rat atria, ATP-
sensitive potassium channels may play a functional role in the regulat
ion of transmitter acetylcholine release from parasympathetic choliner
gic nerve terminals. (C) 1995 The Italian Pharmacological Society